Baltimore, MD26 Active Studies

Ulcerative Colitis Clinical Trials in Baltimore, MD

Find 26 actively recruiting ulcerative colitis clinical trials in Baltimore, MD. Connect with local research sites and explore new treatment options.

26
Active Trials
16
Sponsors
6,903
Enrolling

Recruiting Ulcerative Colitis Studies in Baltimore

About Ulcerative Colitis Clinical Trials in Baltimore

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 26 ulcerative colitis clinical trials recruiting participants in Baltimore, MD. These studies are seeking a combined 6,903 participants. Research is being sponsored by NYU Langone Health, University of Milano Bicocca, University of Pittsburgh and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Baltimore — FAQ

Are there ulcerative colitis clinical trials in Baltimore?

Yes, there are 26 ulcerative colitis clinical trials currently recruiting in Baltimore, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Baltimore?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.

Are clinical trials in Baltimore free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 26 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated July 16, 2026 from ClinicalTrials.gov